These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 31196659

  • 1. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
    Caravaca-Fontán F, Valladares J, Díaz-Campillejo R, Barroso S, Luna E, Caravaca F.
    Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
    [Abstract] [Full Text] [Related]

  • 2. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report.
    Weir MR, Lakkis JI, Jaar B, Rocco MV, Choi MJ, Kramer HJ, Ku E.
    Am J Kidney Dis; 2018 Dec; 72(6):873-884. PubMed ID: 30201547
    [Abstract] [Full Text] [Related]

  • 3. Discontinuation of RAAS Inhibition in Children with Advanced CKD.
    van den Belt SM, Heerspink HJL, Kirchner M, Gracchi V, Thurn-Valsassina D, Bayazit AK, Niemirska A, Canpolat N, Kaplan Bulut I, Azukaitis K, Duzova A, Bacchetta J, Shroff R, Paripovic D, Özçakar ZB, Fidan K, Erdogan H, Gellermann J, Wühl E, de Zeeuw D, Melk A, Querfeld U, Schaefer F.
    Clin J Am Soc Nephrol; 2020 May 07; 15(5):625-632. PubMed ID: 32253275
    [Abstract] [Full Text] [Related]

  • 4. The renin-angiotensin-aldosterone system blockade in patients with advanced diabetic kidney disease.
    Bermejo S, García CO, Rodríguez E, Barrios C, Otero S, Mojal S, Pascual J, Soler MJ.
    Nefrologia (Engl Ed); 2018 May 07; 38(2):197-206. PubMed ID: 29102270
    [Abstract] [Full Text] [Related]

  • 5. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T, Nakayama K, Ochi A, Amemiya N, Tsuruta Y, Kojima C, Itabashi M, Takei T, Uchida K, Nitta K.
    Clin Exp Nephrol; 2012 Apr 07; 16(2):231-7. PubMed ID: 22038185
    [Abstract] [Full Text] [Related]

  • 6. Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
    Yue C, Li G, Wen Y, Li X, Gao R.
    J Rheumatol; 2018 May 07; 45(5):655-662. PubMed ID: 29449503
    [Abstract] [Full Text] [Related]

  • 7. Association between early worsening of kidney function and poor outcomes in patients treated with renin angiotensin system inhibitors: A meta-analysis.
    Yuan S, Liu Y, He W, Jin J, Liu L, He Q.
    Nephrology (Carlton); 2021 Oct 07; 26(10):772-781. PubMed ID: 34165226
    [Abstract] [Full Text] [Related]

  • 8. Underprescription of renin-angiotensin system blockers in moderate to severe chronic kidney disease.
    Shirazian S, Grant CD, Mujeeb S, Sharif S, Kumari P, Bhagat M, Mattana J.
    Am J Med Sci; 2015 Jun 07; 349(6):510-5. PubMed ID: 26030613
    [Abstract] [Full Text] [Related]

  • 9. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ.
    Am J Kidney Dis; 2021 May 07; 77(5):719-729.e1. PubMed ID: 33246024
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
    Lin CC, Wu YT, Yang WC, Tsai MJ, Liu JS, Yang CY, Li SY, Ou SM, Tarng DC, Hsu CC.
    PLoS One; 2017 May 07; 12(12):e0189126. PubMed ID: 29216260
    [Abstract] [Full Text] [Related]

  • 11. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul 07; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 12. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.
    Oh YJ, Kim SM, Shin BC, Kim HL, Chung JH, Kim AJ, Ro H, Chang JH, Lee HH, Chung W, Lee C, Jung JY.
    PLoS One; 2017 Jul 07; 12(1):e0170874. PubMed ID: 28122064
    [Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
    Sedláková L, Čertíková Chábová V, Doleželová Š, Škaroupková P, Kopkan L, Husková Z, Červenková L, Kikerlová S, Vaněčková I, Sadowski J, Kompanowska-Jezierska E, Kujal P, Kramer HJ, Červenka L.
    Clin Exp Hypertens; 2017 Jul 07; 39(2):183-195. PubMed ID: 28287881
    [Abstract] [Full Text] [Related]

  • 14. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study.
    Voskamp PWM, Dekker FW, van Diepen M, Hoogeveen EK, PREPARE-2 Study Group.
    J Am Soc Hypertens; 2017 Oct 07; 11(10):635-643. PubMed ID: 28802945
    [Abstract] [Full Text] [Related]

  • 15. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
    Brosnahan GM, Abebe KZ, Moore CG, Bae KT, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Rahbari-Oskoui FF, Steinman TI, Torres VE, The Halt Pkd Investigators.
    Curr Hypertens Rev; 2018 Oct 07; 14(1):39-47. PubMed ID: 29564978
    [Abstract] [Full Text] [Related]

  • 16. Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study.
    Noh Y, Lee J, Shin S, Park I, Bae SK, Oh E, Lee S.
    Int J Clin Pharm; 2018 Feb 07; 40(1):160-168. PubMed ID: 29282632
    [Abstract] [Full Text] [Related]

  • 17. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R, Rios P, Baldovinos G, Chichet MA, Perg N, Sola L, Saona G, De Souza N, Lamadrid V, Gadola L.
    Nephron; 2019 Feb 07; 143(2):100-107. PubMed ID: 31203280
    [Abstract] [Full Text] [Related]

  • 18. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
    Caravaca-Fontán F, Valladares J, Díaz-Campillejo R, Barroso S, Luna E, Caravaca F.
    Nefrologia (Engl Ed); 2019 Feb 07; 39(5):513-522. PubMed ID: 31027897
    [Abstract] [Full Text] [Related]

  • 19. Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
    Bhandari S, Mehta S, Khwaja A, Cleland JGF, Ives N, Brettell E, Chadburn M, Cockwell P, STOP ACEi Trial Investigators.
    N Engl J Med; 2022 Dec 01; 387(22):2021-2032. PubMed ID: 36326117
    [Abstract] [Full Text] [Related]

  • 20. Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study.
    Endo K, Hayashi K, Hara Y, Miyake A, Takano K, Horikawa T, Yoshino K, Sakai M, Kitamura K, Ito S, Imai N, Fujitani S, Suzuki T.
    BMC Nephrol; 2023 Mar 22; 24(1):68. PubMed ID: 36949416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.